NCT00185887View on ClinicalTrials.gov

Nitroglycerin Versus Terbutaline for Intrapartum Fetal Resuscitation

NACompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

July 31, 2006

Study Completion Date

October 31, 2007

Conditions
Fetal Distress
Interventions
DRUG

Terbutaline

Terbutaline 250 micrograms intravenously for intrapartum fetal resuscitation. Nitroglycerine 400 micrograms intravenously for intrapartum fetal resuscitation.

Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT00185887 - Nitroglycerin Versus Terbutaline for Intrapartum Fetal Resuscitation | Biotech Hunter | Biotech Hunter